** Shares of Shuttle Pharmaceuticals Inc SHPH.O more than
double in their market debut to trade at $17.50
** Co late on Tuesday priced its offering of nearly 1.2 mln
units of common stock and warrants at $8.125/unit urn:newsml:reuters.com:*:nPn4jcMZKa
** Boustead Securities Llc and Valuable Capital Ltd were
underwriters for the IPO
** SHPH is developing radiation sensitizers, which are
agents that make it easier for radiation therapy to kill cancer
cells
(Reporting by Raghav Mahobe)
((Raghav.Mahobe@thomsonreuters.com;))